28
Participants
Start Date
November 30, 2005
Primary Completion Date
November 30, 2008
Study Completion Date
December 31, 2008
ondansetron, ibuprofen, paracetamol
ondansetron 4mg bid + Ibuprofen 200mg qds + paracetamol 1g qds days 1-6 inclusive of rIL-2 dosing cycle
Ondansetron, ibuprofen, paracetamol
Ondansetron 4mg bid + codeine phosphate 15mg tds + Ibuprofen 200mg qds + paracetamol 1g qds days 1-6 inclusive of rIL-2 dosing cycle
metoclopramide, ibuprofen, paracetamol
metoclopramide 10mg qds + Ibuprofen 200mg qds + paracetamol 1g qds days 1-6 inclusive of rIL-2 dosing cycle
Metoclopramide, codeine phosphate, ibuprofen, paracetamol
metoclopramide 10mg qds + codeine phosphate 15mg tds + Ibuprofen 200mg qds + paracetamol 1g qds days 1-6 inclusive of rIL-2 dosing cycle
St. Vincent's Hospital, Sydney
Carlton Clinic, Melbourne
The Alfred Hospital, Melbourne
AIDS Medical Unit, Brisbane
Gold Coast Sexual Health Clinic, Gold Coast
Nambour Hospital, Nambour
Cairns Base Hospital, Cairns
Hospital General de Agudos JM Ramos Mejia, Buenos Aires
FUNCEI, Buenos Aires
Hospital Italiano de Buenos Aires, Buenos Aires
Hospital Prof. Alejandro Posadas, Buenos Aires
Hospital Interzonal de Agudos San Juan de Dios, La Plata
Hospital Interzonal General de Agudos Oscar Alende, Mar del Plata
Hospital Central, Mendoza
CAICI, Rosario
Kaplan Medical Center, Rehovot
Lead Sponsor
The University of New South Wales
OTHER
Kirby Institute
OTHER_GOV